Patent Assignment
Reel/Frame 059436/0131
Assignment of Assignor's Interest
Recorded: 2022-03-18
Pages: 26
Assignor
BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Executed: 2016-06-02
Assignee
REVANCE THERAPEUTICS, INC.
7555 GATEWAY BOULEVARD, NEWARK, CALIFORNIA, 94560
Covered Property
(1)
Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 18, 2022
From: BORODIC, GARY E.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 059439/0940 →
Security Interest
Mar 18, 2022
From: REVANCE THERAPEUTICS, INC.
To: ATHYRIUM BUFFALO LP
Reel/Frame 059437/0654 →
Release of Security Interest
Feb 7, 2025
From: ATHYRIUM BUFFALO LP
To: REVANCE THERAPEUTICS, INC
Reel/Frame 070153/0630 →
Security Interest
Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0663 →
Security Interest
Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; BELLUS MEDICAL, LLC; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0736 →
Security Interest
Feb 17, 2025
From: REVANCE THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 070239/0739 →